BR0212261A - Composto, processo para a preparação e utilização desse composto - Google Patents
Composto, processo para a preparação e utilização desse compostoInfo
- Publication number
- BR0212261A BR0212261A BR0212261-8A BR0212261A BR0212261A BR 0212261 A BR0212261 A BR 0212261A BR 0212261 A BR0212261 A BR 0212261A BR 0212261 A BR0212261 A BR 0212261A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- preparing
- protecting group
- group
- diols
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- 102000005348 Neuraminidase Human genes 0.000 abstract 1
- 108010006232 Neuraminidase Proteins 0.000 abstract 1
- 125000006242 amine protecting group Chemical group 0.000 abstract 1
- 125000006244 carboxylic acid protecting group Chemical group 0.000 abstract 1
- 150000002009 diols Chemical class 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 125000006239 protecting group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pulmonology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pyrane Compounds (AREA)
Abstract
"COMPOSTO, PROCESSO PARA A PREPARAçãO E UTILIZAçãO DESSE COMPOSTO". Expõem-se compostos da fórmula (I), processos para a sua preparação e sua utilização na manufatura de conjugados inibidores de neuraminidase, em que R representa um grupo de proteção de ácido carboxílico; P~ 1~ e P~ 2~ podem ser o mesmo ou diferentes e são selecionados a partir de grupos de proteção de amina; P~ 3~ representa um grupo de proteção para 1,2 dióis; e LG representa um grupo retirante.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPR757401 | 2001-09-07 | ||
PCT/AU2002/001187 WO2003022841A1 (en) | 2001-09-07 | 2002-08-30 | Intermediates for preparing neuraminidase inhibitor conjugates |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0212261A true BR0212261A (pt) | 2004-10-19 |
Family
ID=3831510
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0212261-8A BR0212261A (pt) | 2001-09-07 | 2002-08-30 | Composto, processo para a preparação e utilização desse composto |
Country Status (12)
Country | Link |
---|---|
US (1) | US7230114B2 (pt) |
EP (1) | EP1423385B1 (pt) |
JP (1) | JP4463553B2 (pt) |
AT (1) | ATE399779T1 (pt) |
BR (1) | BR0212261A (pt) |
CA (1) | CA2456239C (pt) |
DE (1) | DE60227386D1 (pt) |
DK (1) | DK1423385T3 (pt) |
ES (1) | ES2307776T3 (pt) |
MX (1) | MXPA04002141A (pt) |
PT (1) | PT1423385E (pt) |
WO (1) | WO2003022841A1 (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015032357A1 (zh) * | 2013-09-09 | 2015-03-12 | 中国科学院上海有机化学研究所 | 扎那米韦和拉那米韦的中间体及其合成方法 |
CN113461631B (zh) * | 2021-06-29 | 2022-10-14 | 上海应用技术大学 | 一种1,3,4-恶二唑类神经氨酸酶抑制剂及其制备方法与应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9516276D0 (en) * | 1995-08-08 | 1995-10-11 | Biota Scient Management | Chemical compounds |
ATE238552T1 (de) | 1996-03-01 | 2003-05-15 | Biota Scient Management | Verfahren zum nachweis von influenza-virus und dazu verwendbare verbindungen |
ATE239006T1 (de) * | 1996-08-13 | 2003-05-15 | Sankyo Co | Verbindungen der neuraminsaeure |
AUPR001000A0 (en) * | 2000-09-08 | 2000-10-05 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
-
2002
- 2002-08-30 DK DK02759906T patent/DK1423385T3/da active
- 2002-08-30 MX MXPA04002141A patent/MXPA04002141A/es active IP Right Grant
- 2002-08-30 BR BR0212261-8A patent/BR0212261A/pt not_active IP Right Cessation
- 2002-08-30 DE DE60227386T patent/DE60227386D1/de not_active Expired - Lifetime
- 2002-08-30 CA CA2456239A patent/CA2456239C/en not_active Expired - Fee Related
- 2002-08-30 AT AT02759906T patent/ATE399779T1/de not_active IP Right Cessation
- 2002-08-30 JP JP2003526916A patent/JP4463553B2/ja not_active Expired - Fee Related
- 2002-08-30 EP EP02759906A patent/EP1423385B1/en not_active Expired - Lifetime
- 2002-08-30 ES ES02759906T patent/ES2307776T3/es not_active Expired - Lifetime
- 2002-08-30 US US10/488,791 patent/US7230114B2/en not_active Expired - Fee Related
- 2002-08-30 PT PT02759906T patent/PT1423385E/pt unknown
- 2002-08-30 WO PCT/AU2002/001187 patent/WO2003022841A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
PT1423385E (pt) | 2008-09-24 |
CA2456239A1 (en) | 2003-03-20 |
ES2307776T3 (es) | 2008-12-01 |
US7230114B2 (en) | 2007-06-12 |
DK1423385T3 (da) | 2008-11-03 |
JP4463553B2 (ja) | 2010-05-19 |
MXPA04002141A (es) | 2004-07-23 |
ATE399779T1 (de) | 2008-07-15 |
US20050032853A1 (en) | 2005-02-10 |
CA2456239C (en) | 2010-11-30 |
EP1423385A1 (en) | 2004-06-02 |
WO2003022841A1 (en) | 2003-03-20 |
JP2005501921A (ja) | 2005-01-20 |
DE60227386D1 (de) | 2008-08-14 |
EP1423385B1 (en) | 2008-07-02 |
EP1423385A4 (en) | 2004-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0210464A (pt) | Composto, composição farmacêutica, processo para preparar um composto, e, uso de um composto | |
BR0206433A (pt) | Composto, composição farmacêutica, processo para a prepapação de um composto, e, uso de um composto | |
BR0010555A (pt) | Inibidores de neuraminidases | |
BR0309546A (pt) | Composto, composição farmacêutica que compreende o mesmo, processo para a sua preparação e utilização e método para tratamento profilático ou terapêutico de diabetes do tipo ii | |
BR0314113A (pt) | Derivados de amino propanol | |
BR0114576A (pt) | Composto, composição farmacêutica, uso de um composto, método de tratar um estado doentio e processo para preparar um composto | |
BR9707958A (pt) | Composto, composição farmacêutica, e, processo para tratar hiperalgesia em um paciente. | |
BR0214559A (pt) | sais de ácido succìnico do 5,8,14-triazatetraciclo [10.3.1.0<2,11>.0<4,9>]-hexadeca-2(11),3,5,7,9-penteno e suas composições farmacêuticas | |
BR9916633A (pt) | Benzopiranos e benzoxepinas, composições farmacêuticas compreendendo-as e processo de preparação | |
BR0212069A (pt) | Agentes antidiabéticos orais | |
BR0211422A (pt) | Processo para a preparação de um composto ou de um éster ou um sal do mesmo, e, composto | |
BR0213481A (pt) | Sondas | |
BR9708233A (pt) | Processo para sìntese de um composto e composto. | |
BRPI0512951A (pt) | compostos, processo para sua fabricação, composições farmacêuticas contendo os mesmos, uso e método para tratamento e/ou prevenção de doenças que são moduladas pelos agonistas de ppar(delta) e/ou ppar(alpha) | |
BRPI0411308A (pt) | composto, composição farmacêutica, processo para a preparação de um composto, e, uso de um composto | |
BR0012631A (pt) | Processo para a preparação de compostos de amina | |
BR0210278A (pt) | Processo para a preparação de l-ribavirina | |
BR9705456A (pt) | Compostos heterocìclicos, processo de aminometila para sua preparação e composições farmacêuticas que os contêm. | |
BR9813217A (pt) | Tetraciclos, processo para a produção dos mesmos e preparações farmacêuticas contendo estes compostos | |
BR0007982A (pt) | Processo para a preparação de um composto, e,composto | |
BR9911250A (pt) | Processo para preparação de compostos | |
BR0113259A (pt) | Processo para a preparação de um composto, composto e processo para a preparação de compostos | |
BR0212261A (pt) | Composto, processo para a preparação e utilização desse composto | |
BR0308601A (pt) | inibidores de carboxipeptidase b de plasma | |
BR0114258A (pt) | Esteróides de 17alfa-fluoroalquila, processo para sua produção e composições farmacêuticas que contêm estes compostos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Free format text: PARA INT.CL: C07D 407/06, C07D 407/14, A61P 31/00 Ipc: C07D 407/06 (2011.01), C07D 407/14 (2011.01) |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 12A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2269 DE 01/07/2014. |
|
B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] |
Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI. |